Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19

Antigen-specific vaccines developed for the COVID-19 pandemic demonstrate a remarkable achievement and are currently being used in high income countries with much success. However, new SARS-CoV-2 variants are threatening this success via mutations that lessen the efficacy of antigen-specific antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Alexandra L., Sharpe, Sally, White, Andrew D., Bodman-Smith, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455994/
https://www.ncbi.nlm.nih.gov/pubmed/34567010
http://dx.doi.org/10.3389/fimmu.2021.743924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455994/
https://www.ncbi.nlm.nih.gov/pubmed/34567010
http://dx.doi.org/10.3389/fimmu.2021.743924

Ejemplares similares